Market Overview

UPDATE: Wedbush Raises PT to $56 on Pentair; Outlook Intact

Related PNR
Biotechs Among Stocks That Insiders Have Been Buying Lately
Earnings Scheduled For October 20, 2015
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q3 2015 Update (Seeking Alpha)

Wedbush reiterated its Outperform rating on Pentair (NYSE: PNR) and raised its price target from $54.00 to $56.00.

Wedbush noted, "Synergy targets remain on track, although greater benefits to be realized in back-half of year. Though the quarter was messy, as expected, operating results were essentially in line. The $90 million goal in cost synergies appears to be on track as most of the repositioning actions have taken place in Q4. However, most of these benefits will accrue to the company in the second half, with no material benefit in Q1 as consensus anticipated."

Pentair closed at $50.71 on Tuesday.

Latest Ratings for PNR

Oct 2015Stifel NicolausDowngradesBuy
Oct 2015Morgan StanleyInitiates Coverage onEqual-weight
Oct 2015Goldman SachsReinstatesNeutral

View More Analyst Ratings for PNR
View the Latest Analyst Ratings

Posted-In: WedbushAnalyst Color Price Target Analyst Ratings


Related Articles (PNR)

View Comments and Join the Discussion!

Get Benzinga's Newsletters